Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?

Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134 · see citing works

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 3× · see citing works

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953 · see citing works

Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein

Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865 · see citing works

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

Leimbach, W., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986) · Circulation · doi:10.1161/01.cir.73.5.913 · Cited by 810 · see citing works

Profound neuronal plasticity in response to inactivation of the dopamine transporter.

Jones, S., Gainetdinov, R., Jaber, M., Giros, B., Wightman, R., & Caron, M. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.7.4029 · Cited by 729 · see citing works

APPLICATION OF STEADY STATE KINETICS TO THE ESTIMATION OF SYNTHESIS RATE AND TURNOVER TIME OF TISSUE CATECHOLAMINES

Brodie, B. B., Costa, E., Dlabač, A., Neff, N. H., & Smookler, H. H. (1966) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27496-1 · Cited by 710 · see citing works

Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency

Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 2× · see citing works

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 589 · see citing works

Catecholamine metabolism: basic aspects and clinical significance.

Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582 · see citing works

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1956 · Cited by 547 · see citing works

A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines

Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503 · see citing works

Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results

Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030005 · Cited by 492 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein Is Sensitive to Parkinson's Disease-Linked Mutations and Occurs by a Pore-like Mechanism

Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 485 · see citing works

Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464 · see citing works

Cardiac Sympathetic Nerve Function in Congestive Heart Failure

Eisenhofer, G., Friberg, P., Rundqvist, B., Quyyumi, A. A., Lambert, G., Kaye, D. M., Kopin, I. J., Goldstein, D. S., & Esler, M. D. (1996) · Circulation · doi:10.1161/01.cir.93.9.1667 · Cited by 453 · see citing works

Substantial Production of Dopamine in the Human Gastrointestinal Tract

Eisenhofer, G., Åneman, A., Friberg, P., Hooper, D., Fåndriks, L., Lonroth, H., Hunyady, B., & Mezey, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4339 · Cited by 394 · see citing works

AMINE OXIDASE AND AMINE METABOLISM

Blaschko, H. K. F. (1952) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06961-3 · Cited by 380 · see citing works

The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines.

Eisenhofer, G. (2001) · Pharmacology and Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 373 · see citing works

Cardiac Sympathetic Denervation in Parkinson Disease

Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00009 · Cited by 372 · see citing works

Dopamine transporters and neuronal injury

Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371 · see citing works

Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Singaram, C., Gaumnitz, E., Torbey, C., Ashraf, W., Quigley, E. M., Sengupta, A., & Pfeiffer, R. F. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 364 · see citing works

3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine

Armstrong, M. D., McMillan, A., & Shaw, K. N. F. (1957) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(57)90491-2 · Cited by 353 · see citing works

Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel–Lindau Disease and Multiple Endocrine Neoplasia Type 2

Eisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 346 · see citing works

Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

Michel, P. P., & Hefti, F. F. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260405 · Cited by 339 · see citing works

Vesicular neurotransmitter transporters: from bacteria to humans.

Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 329 · see citing works

Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure

Rundqvist, B., Elam, M., Sverrisdóttir, Y. B., Eisenhofer, G., & Friberg, P. (1997) · Circulation · doi:10.1161/01.cir.95.1.169 · Cited by 308 · see citing works

Frontiers in Biochemical and Pharmacological Research in Depression

Usdin, E. (1984) · Medical Entomology and Zoology · Cited by 278 · see citing works

Neurobiology of retinal dopamine in relation to degenerative states of the tissue

Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00129-6 · Cited by 274 · see citing works

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease

Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 267 · see citing works

Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows.

Kuroda, S., & Siesjö, B. K. (1997) · PubMed · Cited by 263 · see citing works

Orthostatic hypotension from sympathetic denervation in Parkinson’s disease

Goldstein, D. S., Holmes, C. S., Dendi, R., BRUCE, S. R., & Li, S.-T. (2002) · Neurology · doi:10.1212/wnl.58.8.1247 · Cited by 258 · see citing works

Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease

Offen, D., Ziv, I., Sternin, H., Melamed, E., & Hochman, A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0136 · Cited by 250 · see citing works

Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R., & Kopin, I. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113298 · Cited by 245 · see citing works

Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol- O -Methyltransferase Within Tumors

Eisenhofer, G., Keiser, H. R., Friberg, P., Mezey, É., Huynh, T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A. M. M., & Lenders, J. W. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4870 · Cited by 242 · see citing works

Plasma Metanephrines in the Diagnosis of Pheochromocytoma

Lenders, J. W. M., Keiser, H. R., Goldstein, D. S., Willemsen, J. J., Friberg, P., Jacobs, M.-C., Kloppenborg, P. W. C., Thien, T., & Eisenhofer, G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00004 · Cited by 242 · see citing works

Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice

Fumagalli, F., Gainetdinov, R. R., Wang, Y., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241 · see citing works

Abnormalities in color vision and contrast sensitivity in Parkinson's disease

Price, M. J., Feldman, R. G., Adelberg, D. A., & Kayne, H. L. (1992) · Neurology · doi:10.1212/wnl.42.4.887 · Cited by 236 · see citing works

Evidence for reduction of norepinephrine uptake sites in the failing human heart

Böhm, M., Rosée, K. L., Schwinger, R. H., & Erdmann, E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00353-r · Cited by 235 · see citing works

STORAGE AND METABOLISM OF CATECHOLAMINES: THE ROLE OF MONOAMINE OXIDASE.

KOPIN, I. J. (1964) · PubMed · Cited by 235 · see citing works

Isoquinoline neurotoxins in the brain and Parkinson's disease

Nagatsu, T. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00083-7 · Cited by 229 · see citing works

3-Methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid

Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., & Kopin, I. J. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90119-6 · Cited by 228 · see citing works

Pheochromocytoma in Italy: a multicentric retrospective study

Mannelli, M., Ianni, L., Cilotti, A., & Conti, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410619 · Cited by 227 · see citing works

Gastrointestinal dysfunction in Parkinson's disease

Edwards, L., Quigley, E., & Pfeiffer, R. (1992) · Neurology · doi:10.1212/wnl.42.4.726 · Cited by 226 · see citing works

The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.

Cohen, G. (1983) · PubMed · Cited by 224 · see citing works

Determination of metanephrines in plasma by liquid chromatography with electrochemical detection

Lenders, J. W. M., Eisenhofer, G., Armando, I., Keiser, H. R., Goldstein, D. S., & Kopin, I. J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.1.97 · Cited by 220 · see citing works

Catecholamine toxicity in cerebral cortex in dissociated cell culture

Rosenberg, P. A. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02887.1988 · Cited by 209 · see citing works

Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection

Filloux, F. M., & Townsend, J. J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1008 · Cited by 207 · see citing works

Relation Between Plasma and Cerebrospinal Fluid Levels of 3-Methoxy-4-Hydroxyphenylglycol

Kopin, I. J., Gordon, E. K., Jimerson, D. C., & Polinsky, R. J. (1983) · Science · doi:10.1126/science.6849119 · Cited by 204 · see citing works

Brain Aldehyde Dehydrogenase

Erwin, V. G., & Deitrich, R. A. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99864-9 · Cited by 203 · see citing works

Turnover and Metabolism of Catecholamines in Patients with Pheochromocytoma*

Crout, J. R., & Sjoerdsma, A. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104898 · Cited by 201 · see citing works

Conversion of MHPG to Vanillylmandelic Acid

Blombery, P. A. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780230013001 · Cited by 200 · see citing works

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

Nagatsu, T., & Yoshida, M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90166-8 · Cited by 198 · see citing works

Reperfusion injury

Flaherty, J. T., & Weisfeldt, M. L. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90115-3 · Cited by 198 · see citing works

Dopamine and the Kidney: Ten Years on

Lee, M. R. (1993) · Clinical Science · doi:10.1042/cs0840357 · Cited by 197 · see citing works

The alteration of serotonin metabolism to 5-hydroxytryptophol by ethanol ingestion in man.

Davis, V. E., Brown, H., Huff, J. A., & Cashaw, J. L. (1967) · PubMed · Cited by 189 · see citing works

Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma

Eisenhofer, G., Huynh, T., Hiroi, M., & Pacák, K. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011572617314 · Cited by 182 · see citing works

Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.

Eisenhofer, G., Rundquist, B., Åneman, A., Friberg, P., Dakak, N., Kopin, I. J., Jacobs, M. C., & Lenders, J. W. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559889 · Cited by 181 · see citing works

Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma

Raber, W., Raffesberg, W., Bischof, M. G., Scheuba, C., Niederle, B., Gasic, S., Waldhäusl, W. K., & Roden, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2957 · Cited by 180 · see citing works

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

Maas, J. W., Hattox, S. E., Greene, N. M., & Landis, D. H. (1979) · Science · doi:10.1126/science.472724 · Cited by 179 · see citing works

Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.

Schömig, A., Fischer, S., Kurz, T., Richardt, G., & Schömig, E. (1987) · Circulation Research · doi:10.1161/01.res.60.2.194 · Cited by 178 · see citing works

3-methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine

Axelrod, J. L., Kopin, I. J., & Mann, J. D. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90218-5 · Cited by 177 · see citing works

Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific

Taki, J., Nakajima, K., Hwang, E.-H., Matsunari, I., Komai, K., Yoshita, M., Sakajiri, K., & Tonami, N. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050544 · Cited by 176 · see citing works

Urinary excretion of catecholamines and their metabolites in pheochromocytoma

Crout, J. R., Pisano, J. J., & Sjoerdsma, A. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90609-3 · Cited by 172 · see citing works

The inactivation of adrenaline in vivo in man

Richter, D. (1940) · The Journal of Physiology · doi:10.1113/jphysiol.1940.sp003854 · Cited by 160 · see citing works

Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause

Imamura, Y., Ando, H., Mitsuoka, W., Egashira, S., Masaki, H., Ashihara, T., & Fukuyama, T. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00374-6 · Cited by 159 · see citing works

X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3

Dajani, R., Cleasby, A., Neu, M., Wonacott, A. J., Jhoti, H., Hood, A. M., Modi, S. P., Hersey, A., Taskinen, J., Cooke, R. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37862 · Cited by 158 · see citing works

Neurotransmitter alterations in a model of perinatal hypoxic‐ischemic brain injury

Johnston, M. V. (1983) · Annals of Neurology · doi:10.1002/ana.410130507 · Cited by 155 · see citing works

METABOLISM OF NOREPINEPHRINE-H3 RELEASED BY TYRAMINE AND RESERPINE

Kopin, I. J., & Gordon, E. K. (1962) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26437-0 · Cited by 155 · see citing works

Purification and Characterization of a Reduced Nicotinamide Adenine Dinucleotide Phosphate-linked Aldehyde Reductase from Brain

Tabakoff, B., & Erwin, V. G. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63049-2 · Cited by 152 · see citing works

Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter

Jaber, M., Dumartin, B., Sagné, C., Haycock, J. W., Roubert, C., Bruno Giros, A., Bloch, B., & Caron, M. G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00764.x · Cited by 143 · see citing works

Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

Liang, C., Fan, T.-H., Sullebarger, J. T., & Sakamoto, S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114294 · Cited by 143 · see citing works

Increased striatal dopamine turnover following acute administration of rotenone to mice

Thiffault, C., Langston, J. W., & Monte, D. A. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02960-7 · Cited by 143 · see citing works

Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.

Himura, Y., Felten, S. Y., Kashiki, M., Lewandowski, T. J., Delehanty, J. M., & Liang, C. (1993) · Circulation · doi:10.1161/01.cir.88.3.1299 · Cited by 141 · see citing works

Reduction of Cardiac Tyrosine Hydroxylase Activity in Experimental Congestive Heart Failure

Pool, P. E., Covell, J. W., Levitt, M., Gibb, J. W., & D, E. B. M. (1967) · Circulation Research · doi:10.1161/01.res.20.3.349 · Cited by 136 · see citing works

Adrenaline and amine oxidase

Richter, D. (1937) · Biochemical Journal · doi:10.1042/bj0312022 · Cited by 134 · see citing works

Ethanol-induced alterations of norepinephrine metabolism in man.

Davis, V. E., Brown, H., Huff, J. A., & Cashaw, J. L. (1967) · PubMed · Cited by 131 · see citing works

Effects of Transient Forebrain Ischemia and Pargyline on Extracellular Concentrations of Dopamine, Serotonin, and Their Metabolites in the Rat Striatum as Determined by In Vivo Microdialysis

Damsma, G., Boisvert, D. P. J., Mudrick, L. A., Wenkstern, D., & Fibiger, H. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02322.x · Cited by 130 · see citing works

Membrane-bound catechol-O-methyltransferase: A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters

Roth, J. A. (1992) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0036121 · Cited by 128 · see citing works

Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects.

Nightingale, S., Mitchell, K. W., & Howe, J. W. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.11.1280 · Cited by 126 · see citing works

A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.

Mezey, É., Eisenhofer, G., Harta, G., Hansson, S. R., Gould, L., Hunyady, B., & Hoffman, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10377 · Cited by 125 · see citing works

Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.

Eisenhofer, G., Esler, M., Meredith, I. T., Dart, A. M., Cannon, R. O., Quyyumi, A. A., Lambert, G. W., Chin, J. P. F., Jennings, G., & Goldstein, D. S. (1992) · Circulation · doi:10.1161/01.cir.85.5.1775 · Cited by 125 · see citing works

Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease

Jicha, G. A., Berenfeld, B., & Davies, P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 123 · see citing works

Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?

Eisenhofer, G., Friberg, P., Pacak, K., Goldstein, D. S., Murphy, D. L., Tsigos, C., Quyyumi, A. A., Brunner, H. G., & Lenders, J. W. M. (1995) · Clinical Science · doi:10.1042/cs0880533 · Cited by 123 · see citing works

Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates

Elsworth, J. D., Redmond, D. E., & Roth, R. H. (1982) · Brain Research · doi:10.1016/0006-8993(82)90200-1 · Cited by 122 · see citing works

Sources and Physiological Significance of Plasma Dopamine Sulfate

Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Åneman, A., Holmes, C. S., Lamensdorf, I., & Eisenhofer, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5864 · Cited by 122 · see citing works

Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma

Karoum, F., Moyer-Schwing, J., Potkin, S. G., & Richard, J. W. (1977) · Brain Research · doi:10.1016/0006-8993(77)90626-6 · Cited by 121 · see citing works

The Neuronal Norepinephrine Transporter in Experimental Heart Failure: Evidence for a Posttranscriptional Downregulation

Backs, J., Haunstetter, A., Gerber, S. H., Metz, J., Borst, M. M., Strasser, R. H., Kübler, W., & Haass, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1319 · Cited by 113 · see citing works

Mesenteric Organ Production, Hepatic Metabolism, and Renal Elimination of Norepinephrine and Its Metabolites in Humans

Eisenhofer, G., Åneman, A., Hooper, D., Rundqvist, B., & Friberg, P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041565.x · Cited by 113 · see citing works

Sympathetic activity and neurotransmitter depletion in congestive heart failure.

Chidsey, C. A., & D, E. B. M. (1966) · PubMed · Cited by 113 · see citing works

Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids

DeMet, E. M., & Halaris, A. E. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90611-7 · Cited by 111 · see citing works

Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases

Gerlo, E., & Sevens, C. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.250 · Cited by 110 · see citing works

The vesiicular monoamine transporter: from chromaffin granule to brain

Henry, J., Sagné, C., Bedet, C., & Gasnier, B. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00092-2 · Cited by 108 · see citing works

Catecholamine Metabolism in Neuroblastoma 1 2

Labrosse, E. H., Comoy, E., Bohuon, C., Zucker, J., & Schweisguth, O. (1976) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/57.3.633 · Cited by 107 · see citing works

Hydrogen Peroxide Production by Monoamine Oxidase during Ischemia-Reperfusion in the Rat Brain

Simonson, S. G., Zhang, J., Canada, A. T., Su, Y.-F., Benveniste, H., & Piantadosi, C. A. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.15 · Cited by 107 · see citing works

3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson’s disease pathogenesis

Li, S. W., Lin, T., Minteer, S. D., & Burke, W. J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00120-6 · Cited by 107 · see citing works

An endogenous dopaminergic neurotoxin: Implication for Parkinson's disease

Mattammal, M. B., Haring, J. H., Chung, H. D., Raghu, G., & Strong, R. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90016-0 · Cited by 107 · see citing works

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells

Lamensdorf, I., Eisenhofer, G., Harvey-White, J. D., Nechushtan, A., Kirk, K. L., & Kopin, I. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02309-x · Cited by 105 · see citing works

Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system.

Masserano, J. M., Gong, L., Kulaga, H. M., Baker, I., & Wyatt, R. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09559-8 · Cited by 102 · see citing works

Measurement of Norepinephrine and 3,4-Dihydroxyphenylglycol in Urine and Plasma for the Diagnosis of Pheochromocytoma

Duncan, M. W., Compton, P., Lazarus, L., & Smythe, G. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190303 · Cited by 101 · see citing works

Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.

Port, J. D., Gilbert, E. M., Larrabee, P. S., Mealey, P. C., Volkman, K., Ginsburg, R., Hershberger, R. E., Murray, J., & Bristow, M. R. (1990) · Circulation · doi:10.1161/01.cir.81.3.929 · Cited by 100 · see citing works

Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference

Baker, D. L., Fuchs, R. A., Specio, S. E., Khroyan, T. V., & Neisewander, J. L. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 100 · see citing works

Enzymology and subcellular localization of aldehyde oxidation in rat liver

Tank, A. W., Weiner, H., & Thurman, J. A. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90598-0 · Cited by 99 · see citing works

Inhibition of Brain Vesicular Monoamine Transporter (VMAT2) Enhances 1-Methyl-4-phenylpyridinium Neurotoxicity In Vivo in Rat Striata

Staal, R. G. W., & Sonsalla, P. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39240-7 · Cited by 98 · see citing works

A Single Amino Acid, Glu146, Governs the Substrate Specificity of a Human Dopamine Sulfotransferase, SULT1A3

Dajani, R., Hood, A. M., & Coughtrie, M. W. H. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.942 · Cited by 98 · see citing works

Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol

Eisenhofer, G., Goldstein, D. S., Ropchak, T. G., Nguyen, H. Q., Keiser, H. R., & Kopin, I. J. (1988) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(88)90130-0 · Cited by 98 · see citing works

Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines

Eisenhofer, G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.3009 · Cited by 98 · see citing works

Is the autoxidation of catecholamines involved in ischemia-reperfusion injury?

Jewett, S. L., Eddy, L. J., & Hochstein, P. E. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90116-0 · Cited by 95 · see citing works

Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension

Rumantir, M. S., Kaye, D. M., Jennings, G. L., Vaz, M., Hastings, J. A., & Esler, M. D. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.824 · Cited by 95 · see citing works

Reactive Dopamine Metabolites and Neurotoxicity

Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9480-9_13 · Cited by 94 · see citing works

Dopamine sulphate: an enigma resolved.

Eisenhofer, G., Coughtrie, M. W. H., & Goldstein, D. S. (1999) · PubMed · Cited by 93 · see citing works

Direct determination of homovanillic acid release from the human brain, and indicator of central dopaminergic activity

Lambert, G. W., Eisenhofer, G., Cox, H. S., Horne, M. K., Kalff, V., KELLY, M. J., Jennings, G., & Esler, M. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90593-z · Cited by 91 · see citing works

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

Lamensdorf, I., Eisenhofer, G., Harvey-White, J. D., Hayakawa, Y., Kirk, K., & Kopin, I. J. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000515)60:4 · Cited by 90 · see citing works

Derivation of Urinary Dopamine from Plasma Dihydroxyphenylalanine in Humans

Wolfovitz, E., Grossman, E., Folio, C. J., Keiser, H. R., Kopin, I. J., & Goldstein, D. S. (1993) · Clinical Science · doi:10.1042/cs0840549 · Cited by 88 · see citing works

Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover.

Åneman, A., Eisenhofer, G., Olbe, L. C., Dalenbäck, J., Nitescu, P. V., Fändriks, L., & Friberg, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118590 · Cited by 84 · see citing works

Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons

Burke, R. E., Macaya, A., DeVivo, D. C., Kenyon, N. J., & Janec, E. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90447-a · Cited by 80 · see citing works

Is There a Third Peripheral Catecholaminergic System? Endogenous Dopamine as an Autocrine/ Paracrine Substance Derived from Plasma DOPA and Inactivated by Conjugation

Goldstein, D. S., Mezey, É., Yamamoto, T., Åneman, A., Friberg, P., & Eisenhofer, G. (1995) · Hypertension Research · doi:10.1291/hypres.18.supplementi_s93 · Cited by 80 · see citing works

Turnover rates of norepinephrine in hearts of intact mice, rats and guinea pigs using tritiated norepinephrine

Montanari, R., Costa, E., Beaven, M. A., & Brodie, B. B. (1963) · Life Sciences · doi:10.1016/0024-3205(63)90003-1 · Cited by 79 · see citing works

Dynamic Storage of Dopamine in Rat Brain Synaptic Vesicles In Vitro

Floor, E., Leventhal, P. S., Wang, Y., Meng, L., & Chen, W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020689.x · Cited by 79 · see citing works

Dopamine and Iron Induce Apoptosis in PC12 Cells

Velez‐Pardo, C., Jiménez-Del-Río, M., Verschueren, H., Ebinger, G., & Vauquelin, G. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00287.x · Cited by 77 · see citing works

Effects of hypoxia‐ischemia on monoamine metabolism in the immature brain

Silverstein, F. S., & Johnston, M. V. (1984) · Annals of Neurology · doi:10.1002/ana.410150407 · Cited by 74 · see citing works

Effect of eating bananas on plasma free and sulfate-conjugated catecholamines

Davidson, L., Vandongen, R., & Beilin, L. J. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90187-9 · Cited by 74 · see citing works

Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within Tumors

Eisenhofer, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2175 · Cited by 74 · see citing works

Studies on the metabolism of norepinephrine, epinephrine and their o-methyl analogs by partially purified enzyme preparations

Leeper, L. C., Weissbach, H., & Udenfriend, S. (1958) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(58)90089-4 · Cited by 73 · see citing works

Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.

Merlet, P., Pouillart, F., Dubois-Randé, J.-L., Delahaye, N., Fumey, R., Castaigne, A., & Syrota, A. (1999) · PubMed · Cited by 73 · see citing works

Enzymatic Reduction of "Biogenic" Aldehydes in Brain

Tabakoff, B., Anderson, R., & Alivisatos, S. G. A. (1973) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13947-3 · Cited by 70 · see citing works

Dopaminergic Neurotoxicity of Cyanide: Neurochemical, Histological, and Behavioral Characterization

Kanthasamy, A. G., Borowitz, J. L., Pavlaković, G., & Isom, G. E. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1102 · Cited by 69 · see citing works

SOME ENZYMIC ASPECTS OF THE PRODUCTION OF OXIDIZED OR REDUCED METABOLITES OF CATECHOLAMINES AND 5‐HYDROXYTRYPTAMINE BY BRAIN TISSUES

Duncan, R. J. S., & Sourkes, T. L. (1974) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1974.tb04278.x · Cited by 67 · see citing works

Determinants of cardiac noradrenaline depletion in human congestive failure

DeQuattro, V. L., Nagatsu, T., MENDEZ, A., & Verska, J. J. (1973) · Cardiovascular Research · doi:10.1093/cvr/7.3.344 · Cited by 64 · see citing works

Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals.

Weinberger, J. M., Cohen, G., & Nieves-Rosa, J. (1983) · Stroke · doi:10.1161/01.str.14.6.986 · Cited by 63 · see citing works

Activation of Pro-Apoptotic Cascade by Dopamine in Renal Epithelial Cells is Fully Dependent on Hydrogen Peroxide Generation by Monoamine Oxidases

Bianchi, P., Séguélas, M., Parini, A., & Cambon, C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000058909.00567.5c · Cited by 63 · see citing works

Metabolism of some phenylethylamines and their beta-hydroxylated analogs in brain.

Breese, G. R., Chase, T. N., & Kopin, I. J. (1969) · PubMed · Cited by 63 · see citing works

Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease

Moser, A., Scholz, J., Nobbe, F. A., Vieregge, P., Böhme, V., & Bamberg, H. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00110-n · Cited by 62 · see citing works

STORAGE AND MENTABOLISM OF CATECHOLAMINES: THE ROLE OF MONOAMINE OXIDASE

Kopix, I. J. (1964) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07031-0 · Cited by 62 · see citing works

Apoptosis in substantia nigra following developmental hypoxic-ischemic injury

Oo, T. F., Henchcliffe, C., & Burke, R. E. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00282-n · Cited by 61 · see citing works

Disposition and Metabolism of MHPG in Humans: Application to Studies in Depression

Kopin, I. J., Jimerson, D. C., Markey, S. P., Ebert, M. H., & Polinsky, R. J. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017399 · Cited by 60 · see citing works

Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion

Kunduzova, O., Bianchi, P., Parini, A., & Cambon, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01913-1 · Cited by 60 · see citing works

Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration

Howes, L. G., & Reid, J. L. (1985) · Clinical Science · doi:10.1042/cs0690423 · Cited by 59 · see citing works

Regional homovanillic acid production in humans

Lambert, G. W., Eisenhofer, G., Jennings, G., & Esler, M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90612-7 · Cited by 59 · see citing works

A "Pheo" Lurks: Novel Approaches for Locating Occult Pheochromocytoma

Pacák, K., Goldstein, D. S., Doppman, J. L., Shulkin, B. L., Udelsman, R., & Eisenhofer, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7714 · Cited by 59 · see citing works

Neuronal and extraneuronal uptake and metabolism of catecholamines

Graefe, K. ‐., & Henseling, M. (1983) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(83)90058-7 · Cited by 58 · see citing works

N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.

Naoi, M., Dostert, P., Yoshida, M., & NAGATSU, T. (1993) · PubMed · Cited by 54 · see citing works

Dopamine Produced by the Stomach May Act as a Paracrine/ Autocrine Hormone in the Rat

Mezey, É., Eisenhofer, G., Hansson, S. R., Hunyady, B., & Hoffman, B. J. (1998) · Neuroendocrinology · doi:10.1159/000054332 · Cited by 54 · see citing works

Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.

Eisenhofer, G., Smolich, J. J., Cox, H. S., & Esler, M. (1991) · Circulation · doi:10.1161/01.cir.84.3.1354 · Cited by 54 · see citing works

Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia

Matsui, Y., & Kumagae, Y. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90547-7 · Cited by 54 · see citing works

Endogenous dopamine modulates jejunal sodium absorption during high-salt diet in young but not in adult rats

Finkel, Y., Eklöf, A. C., Granquist, L., Soares-da-Silva, P., & Bertorello, A. M. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90114-7 · Cited by 54 · see citing works

Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine

Eisenhofer, G., Åneman, A., Hooper, D., Holmes, C. S., Goldstein, D. S., & Friberg, P. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.268.4.g641 · Cited by 53 · see citing works

Transient Hypoxia Alters Striatal Catecholamine Metabolism in Immature Brain: An In Vivo Microdialysis Study

Gordon, K., Statman, D., Johnston, M. V., Robinson, T. E., Becker, J. B., & Silverstein, F. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01914.x · Cited by 53 · see citing works

Transmural heterogeneity of norepinephrine uptake in failing human hearts

Beau, S. L., & Saffitz, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90739-0 · Cited by 53 · see citing works

The excretion of dopamine and dopamine metabolites in Parkinson's disease and the effect of diet thereon.

Weil‐Malherbe, H., & Buren, J. M. V. (1969) · PubMed · Cited by 52 · see citing works

Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages

Loughlin, J., Copelman, C. A., Hall, A. C., Armer, T., Young, B. C., LANDON, D. N., & Cuzner, M. L. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970215)47:4 · Cited by 51 · see citing works

Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration

BROWN, M. J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00706.x · Cited by 50 · see citing works

A Soluble Protective Antigen of Trypanosoma brucei

Weitz, B. (1960) · Nature · doi:10.1038/185788b0 · Cited by 50 · see citing works

Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure

Pierpont, G. L., Francis, G. S., DeMaster, E. G., OLIVARI, M. T., Ring, W. S., Goldenberg, I. F., Reynolds, S., & Cohn, J. N. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90234-7 · Cited by 49 · see citing works

Human class I alcohol dehydrogenases catalyze the oxidation of glycols in the metabolism of norepinephrine.

Mårdh, G., Luehr, C. A., & Vallée, B. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4979 · Cited by 46 · see citing works

STUDIES ON THE FORMATION OF 3-METHOXY-4-HYDROXY-D-MANDELIC ACID, A URINARY METABOLITE OF NOREPINEPHRINE AND EPINEPHRINE

Armstrong, M. D., & McMillan, A. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07415-0 · Cited by 44 · see citing works

Non-neuronal dopamine in the gastrointestinal system.

Mezey, É., Eisenhofer, G., Hansson, S. R., Harta, G., Hoffman, B. J., Gallatz, K., Palkovits, M., & Hunyady, B. (1999) · PubMed · Cited by 43 · see citing works

Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG.

Kopin, I. J., Blombery, P. A., Ebert, M. H., Gordon, E. K., Jimerson, D. C., Markey, S. P., & Polinsky, R. J. (1984) · PubMed · Cited by 43 · see citing works

Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes

Ellingson, T., Duddempudi, S., Greenberg, B. D., Hooper, D., & Eisenhofer, G. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00125-5 · Cited by 41 · see citing works

Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?

Peaston, R., & Lai, L. C. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.8.734 · Cited by 40 · see citing works

The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats

Eisenhofer, G., Pecorella, W. A., Pacák, K., Hooper, D., Kopin, I. J., & Goldstein, D. S. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90127-9 · Cited by 40 · see citing works

Neurotransmitter specificity of sympathetic denervation in Parkinson’s disease

Sharabi, Y., Li, S.-T., Dendi, R., Holmes, C. S., & Goldstein, D. S. (2003) · Neurology · doi:10.1212/01.wnl.0000052690.91036.ff · Cited by 39 · see citing works

Acetaldehyde Mediation in the Mechanism of Ethanol-Induced Changes in Norepinephrine Metabolism

Walsh, M. J., Truitt, E. B., & Davis, V. E. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15244-9 · Cited by 39 · see citing works

Cereal ingestion and catecholamine excretion

Hoeldtke, R. D., & Wurtman, R. J. (1974) · Metabolism · doi:10.1016/0026-0495(74)90101-2 · Cited by 38 · see citing works

Design, production and characterization of antibodies discriminating between the phenol-and monoamine-sulphating forms of human phenol sulphotransferase

Rubin, G., Sharp, S., Jones, A. L., Glatt, H. R., Mills, J. A., & Coughtrie, M. W. H. (1996) · Xenobiotica · doi:10.3109/00498259609050256 · Cited by 37 · see citing works

METABOLIC PRODUCTS OF ADRENALINE AND NORADRENALINE IN HUMAN URINE1

Goodall, M. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07418-6 · Cited by 37 · see citing works

Determination of homovanillic acid turnover in man

Änggård, E., Lewander, T., & Sjöquist, B. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90199-4 · Cited by 36 · see citing works

Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion

Akiyama, T. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00219-4 · Cited by 36 · see citing works

Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms

Haskel, Y., & Hanani, M. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087652 · Cited by 35 · see citing works

MAO Inhibitors, Clorgyline and Lazabemide, Prevent Hydroxyl Radical Generation Caused by Brain Ischemia/Reperfusion in Mice

Suzuki, T., Akaike, N., Ueno, K.-I., Tanaka, Y., & Himori, N. (2008) · Pharmacology · doi:10.1159/000139304 · Cited by 35 · see citing works

Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells

Burke, W. J., Schmitt, C. A., Gillespie, K. N., & Li, S. W. (1996) · Brain Research · doi:10.1016/0006-8993(96)00129-1 · Cited by 34 · see citing works

Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats

Eisenhofer, G. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169292 · Cited by 34 · see citing works

Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit

Halbr�gge, T., W�lfel, R., & Graefe, K. ‐. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169681 · Cited by 33 · see citing works

Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation

Lambert, G. W., Kaye, D. M., Vaz, M. A. P., Cox, H. S., Turner, A., Jennings, G., & Esler, M. (1995) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(95)00041-u · Cited by 32 · see citing works

Neuronal Re-Uptake of Noradrenaline by Sympathetic Nerves in Humans

Eisenhofer, G., Esler, M., Meredith, I. T., Ferrier, C. P., Lambert, G. W., & Jennings, G. (1991) · Clinical Science · doi:10.1042/cs0800257 · Cited by 32 · see citing works

Sympathetic Neurocirculatory Failure in Parkinson Disease: Evidence for an Etiologic Role of α-Synuclein

Goldstein, D. S., Li, S., & Kopin, I. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00026 · Cited by 31 · see citing works

Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo

Burke, W. J., Li, S. W., Zahm, D. S., Macarthur, H., Kolo, L. L., Westfall, T. C., Anwar, M., Glickstein, S. B., & Ruggiero, D. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03199-1 · Cited by 31 · see citing works

Effects of Ordinary Meals on Plasma Concentrations of 3,4-Dihydroxyphenylalanine, Dopamine Sulphate and 3,4-Dihydroxyphenylacetic Acid

Eldrup, E., Møller, S. E., Andreasen, J., & Christensen, N. J. (1997) · Clinical Science · doi:10.1042/cs0920423 · Cited by 31 · see citing works

Demonstration of the 3-Methoxy Analog of Norepinephrine in Man

Sjoerdsma, A., King, W. M., Leeper, L. C., & Udenfriend, S. (1958) · Science · doi:10.1126/science.127.3303.876 · Cited by 30 · see citing works

Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits

Eisenhofer, G., Cox, H., & Esler, M. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169445 · Cited by 30 · see citing works

A radioenzymatic microassay for simultaneous measurement of catecholamines and their deaminated metabolites

Vlachakis, N. D., Alexander, N., Velasquez, M. T., & Maronde, R. F. (1979) · Biochemical Medicine · doi:10.1016/0006-2944(79)90019-x · Cited by 30 · see citing works

Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection

Flemström, G., & Säfsten, B. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088112 · Cited by 30 · see citing works

F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE

Chidsey, C. A., & D, E. B. M. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07210-2 · Cited by 30 · see citing works

Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury

Glavin, G. B., & Hall, A. M. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00009-p · Cited by 28 · see citing works

Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism

Izzo, J. L., Thompson, D. A., & Horwitz, D. L. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90593-4 · Cited by 27 · see citing works

Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine

Kawamura, M., Kopin, I. J., Kador, P. F., Sato, S., Tjurmina, O., & Eisenhofer, G. (1997) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(97)00086-6 · Cited by 27 · see citing works

Specific skin lesions occurring in a patient with Hodgkin’s lymphoma

Pagliaro, J. A., & White, S. I. (1999) · Australasian Journal of Dermatology · doi:10.1046/j.1440-0960.1999.00315.x · Cited by 27 · see citing works

Norepinephrine Metabolism in Man Using Deuterium Labelling: Origin of 4‐Hydroxy‐3‐Methoxymandelic Acid

Mårdh, G., & Änggård, E. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09695.x · Cited by 27 · see citing works

Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.

Eisenhofer, G., Ropchak, T. G., Kopin, I. J., & Goldstein, D. S. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22331-x · Cited by 26 · see citing works

Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans

Eisenhofer, G., Rundqvist, B., & Friberg, P. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r626 · Cited by 26 · see citing works

Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma

Lenders, J. W. M., Willemsen, J. J., Beissel, T., KLOPPENBORG, P. W. C., Thien, T. A., & Benraad, T. J. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90105-k · Cited by 25 · see citing works

Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats

Kawamura, M., Eisenhofer, G., Kopin, I. J., Kador, P. F., Lee, Y. S., Tsai, J.-Y., Fujisawa, S., Lizak, M. J., Sinz, A., & Sato, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00121-5 · Cited by 25 · see citing works

Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary

Peyrin, L. (1990) · Journal of Neural Transmission · doi:10.1007/bf01245022 · Cited by 25 · see citing works

A KINETIC STUDY OF THE DISPOSITION OF CIRCULATING NOREPINEPHRINE IN NORMAL MALE SUBJECTS

Maas, J. W., Benensohn, H., & Landis, D. H. (1970) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28634-7 · Cited by 25 · see citing works

Hepatomesenteric release and removal of norepinephrine in swine

Åneman, A., Eisenhofer, G., Fändriks, L., & Friberg, P. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.268.4.r924 · Cited by 23 · see citing works

Reduction of biogenic aldehydes by aldehyde reductase and alcohol dehydrogenase from human liver

Wermuth, B., & ̈nch, J. D. B. M. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90449-0 · Cited by 23 · see citing works

The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients

Filser, J. G., Spira, J., Fischer, M., Gattaz, W. F., & Müller, W. E. G. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90003-9 · Cited by 23 · see citing works

The molecular cloning and expression of a human synaptic vesicle amine transporter that suppresses MPP+ toxicity

Liu, L., Xu, W., Harrington, K. A., & Emson, P. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90282-8 · Cited by 22 · see citing works

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827 · see citing works

Phaeochromocytoma

Lenders, J. W. M., Eisenhofer, G., Mannelli, M., & Pacák, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,541 · see citing works

Metabolomics for Investigating Physiological and Pathophysiological Processes

Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,246 · see citing works

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works

Critical review of electrochemical advanced oxidation processes for water treatment applications

Chaplin, B. P. (2014) · Environmental Science Processes & Impacts · doi:10.1039/c3em00679d · Cited by 870 · see citing works

Neuroblastoma: developmental biology, cancer genomics and immunotherapy

Cheung, N. V., & Dyer, M. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3526 · Cited by 796 · see citing works

Commensal clostridia: Leading players in the maintenance of gut homeostasis

Lopetuso, L. R., Scaldaferri, F., Petito, V., & Gasbarrini, A. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-23 · Cited by 753 · see citing works

Complexity of dopamine metabolism

Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 665 · see citing works

Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice

Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., & Sudo, N. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00341.2012 · Cited by 659 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Preoperative Management of the Pheochromocytoma Patient

Pacák, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1720 · Cited by 569 · see citing works

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works

Catecholaminergic systems in stress: structural and molecular genetic approaches

Kvetnansky, R., Sabban, E. L., & Palkovits, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2006 · Cited by 548 · see citing works

Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons

Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. L. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 530 · see citing works

Cactus stems (Opuntia spp.): A review on their chemistry, technology, and uses

Stintzing, F. C., & Carle, R. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400071 · Cited by 526 · see citing works

Differential effects of differing intensities of acute exercise on speed and accuracy of cognition: a meta-analytical investigation

McMorris, T., & Hale, B. J. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2012.09.001 · Cited by 516 · see citing works

Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system.

Wehrwein, E. A., Orer, H. S., & Barman, S. M. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150037 · Cited by 464 · see citing works

Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours

Lam, A. K.-Y. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9484-5 · Cited by 463 · see citing works

Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis

Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415 · see citing works

Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes

Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 402 · see citing works

Conducting polymer-based electrochemical biosensors for neurotransmitters: A review

Moon, J., Thapliyal, N. B., Hussain, K. K., Goyal, R. N., & Shim, Y. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.11.069 · Cited by 390 · see citing works

Peripheral and central effects of circulating catecholamines

William Tank, A., & Lee Wong, D. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140007 · Cited by 387 · see citing works

Where to Look into the Puzzle of Polyphenols and Health? The Postbiotics and Gut Microbiota Associated with Human Metabotypes

Cortés‐Martín, A., Selma, M. V., Tomás-Barberán, F. A., González‐Sarrías, A., & Espı́n, J. C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900952 · Cited by 305 · see citing works

Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase

Marchitti, S. A., Deitrich, R. A., & Vasiliou, V. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.1 · Cited by 282 · see citing works

Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases

Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D. L., Zecca, L., & Casella, L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 270 · see citing works

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release

Finberg, J. P. M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.010 · Cited by 263 · see citing works

Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development

Grabska-Kobyłecka, I., Szpakowski, P., Król, A., Książek-Winiarek, D., Kobyłecki, A., Głąbiński, A., & Nowak, D. (2023) · Nutrients · doi:10.3390/nu15153454 · Cited by 273 · see citing works

Monoamine oxidases as sources of oxidants in the heart

Kaludercic, N., Mialet‐Perez, J., Paolocci, N., Parini, A., & Lisa, F. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.032 · Cited by 251 · see citing works

Comprehensive mapping of neurotransmitter networks by MALDI–MS imaging

Shariatgorji, M., Nilsson, A., Fridjonsdottir, E., Vallianatou, T., Källback, P., Katan, L., Sävmarker, J., Mantas, I., Zhang, X., Bézard, E., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0551-3 · Cited by 242 · see citing works

The Evolution of Dopamine Systems in Chordates

Yamamoto, K., & Vernier, P. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00021 · Cited by 241 · see citing works

Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice

Chen, L., Ding, Y., Cagniard, B., Laar, A. D. V., Mortimer, A. D., Chi, W., Hastings, T. G., Kang, U. J., & Zhuang, X. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3602-07.2008 · Cited by 238 · see citing works

Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement

Espay, A. J., LeWitt, P. A., & Kaufmann, H. (2014) · Movement Disorders · doi:10.1002/mds.26048 · Cited by 237 · see citing works

Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure

Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A. D., & Koch, W. J. (2007) · Nature Medicine · doi:10.1038/nm1553 · Cited by 236 · see citing works

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

Koopmans, K. P., de Vries, E. G. E., Kema, I. P., Elsinga, P. H., Neels, O. C., Sluiter, W. J., van der Horst‐Schrivers, A. N. A., & Jager, P. L. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70801-4 · Cited by 233 · see citing works

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Robicsek, O., Karry, R., Petit, I., Kesner, N. S., Müller, F.-J., Klein, E., Aberdam, D., & Ben‐Shachar, D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.67 · Cited by 229 · see citing works

The function of gut microbiota in immune-related neurological disorders: a review

Sittipo, P., Choi, J., Lee, S., & Lee, Y. K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02510-1 · Cited by 221 · see citing works

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease

Goldstein, D. S., Sullivan, P., Holmes, C. S., Miller, G. W., Alter, S. P., Strong, R., Mash, D. C., Kopin, I. J., & Sharabi, Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12345 · Cited by 206 · see citing works

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

Eisenhofer, G., Pacák, K., Huynh, T.-T., Qin, N., Bratslavsky, G., Linehan, W. M., Mannelli, M., Friberg, P., Grebe, S. K., Timmers, H. J. L. M., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0211 · Cited by 206 · see citing works

Cellular and molecular mechanisms in the long-term action of antidepressants.

Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gracagni · Cited by 192 · see citing works

A test of the catecholamines hypothesis for an acute exercise–cognition interaction

McMorris, T., Collard, K., Corbett, J., Dicks, M., & Swain, J. P. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.11.007 · Cited by 192 · see citing works

SubpathwayMiner: a software package for flexible identification of pathways

Li, C., Li, X., Miao, Y., Wang, Q., Jiang, W., Xu, C. D., Li, J., Han, J., Zhang, F., Gong, B., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp667 · Cited by 191 · see citing works

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

Käenmäki, M., Tammimäki, A., Myöhänen, T. T., Pakarinen, K., Amberg, C., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06889.x · Cited by 188 · see citing works

Critical Neurotransmitters in the Neuroimmune Network

Hodo, T., de Aquino, M. T. P., Shimamoto, A., & Shanker, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01869 · Cited by 187 · see citing works

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study

Balduzzi, A., Valsecchi, M. G., UDERZO, C., Lorenzo, P. D., Klingebiel, T. E., Peters, C., Starý, J., Felice, M. S., Magyarosy, E., Conter, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66998-x · Cited by 186 · see citing works

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

Pagan, F. L., Hebron, M. L., Wilmarth, B., Torres-Yaghi, Y., Lawler, A., Mundel, E. E., Yusuf, N., Starr, N. J., Anjum, M., Arellano, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4200 · Cited by 185 · see citing works

Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples—A review

Bicker, J., Fortuna, A. C., Alves, G., & Falcão, A. C. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.12.030 · Cited by 182 · see citing works

DIAGNOSIS OF ENDOCRINE DISEASE: Biochemical diagnosis of phaeochromocytoma and paraganglioma

van Berkel, A., Lenders, J. W. M., & Timmers, H. J. L. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0882 · Cited by 177 · see citing works

The Effects of Vitamin B in Depression

Mikkelsen, K., Stojanovska, L., & Apostolopoulos, V. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160920110810 · Cited by 177 · see citing works

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

Goldstein, D. S., Kopin, I. J., & Sharabi, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.006 · Cited by 168 · see citing works

Nerve Stimulation: Immunomodulation and Control of Inflammation

Ulloa, L., Quiróz-González, S., & Rosas, R. T. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.10.006 · Cited by 168 · see citing works

Intermittent Hypoxia Induces Early Functional Cardiovascular Remodeling in Mice

Dematteis, M., Julien, C., Guillermet, C., Sturm, N., Lantuejoul, S., Mallaret, M., Lévy, P., & Gozal, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-238oc · Cited by 167 · see citing works

Microbiome, HPA Axis and Production of Endocrine Hormones in the Gut

Sudo, N. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_8 · Cited by 167 · see citing works

An Overview of Pheochromocytoma

Manger, W. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.001 · Cited by 164 · see citing works

Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability

Marc, D. T., Ailts, J. W., Campeau, D. A., Bull, M. J., & Olson, K. L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.007 · Cited by 164 · see citing works

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.004 · Cited by 164 · see citing works

Catechol-O-methyltransferase gene polymorphism and chronic human pain

Tammimäki, A., & Männistö, P. T. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283560c46 · Cited by 162 · see citing works

Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity

Liaudet, L., Calderari, B., & Pacher, P. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9418-y · Cited by 150 · see citing works

Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies

Goldstein, D. S., Holmes, C. S., & Sharabi, Y. (2012) · Brain · doi:10.1093/brain/aws055 · Cited by 144 · see citing works

Role of the Gut Microbiome in Autism Spectrum Disorders

Pulikkan, J., Mazumder, A., & Grace, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_13 · Cited by 142 · see citing works

Metabolic Effects of Dark Chocolate Consumption on Energy, Gut Microbiota, and Stress-Related Metabolism in Free-Living Subjects

Martin, F., Rezzi, S., Peré‐Trepat, E., Kamlage, B., Collino, S., Leibold, E., Kastler, J., Rein, D., Fay, L. B., & Kochhar, S. (2009) · Journal of Proteome Research · doi:10.1021/pr900607v · Cited by 142 · see citing works

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase

Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., & Wakamatsu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084176 · Cited by 142 · see citing works

The Endoplasmic Reticulum Stress Sensor, ATF6α, Protects against Neurotoxin-induced Dopaminergic Neuronal Death

Egawa, N., Yamamoto, K., Inoue, H., Hikawa, R., Nishi, K., Mori, K., & Takahashi, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156430 · Cited by 138 · see citing works

Catechols in post-mortem brain of patients with Parkinson disease

Goldstein, D. S., Sullivan, P., Holmes, C. S., Kopin, I. J., Basile, M. J., & Mash, D. C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03246.x · Cited by 137 · see citing works

Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update

Tripathi, R. K. P., & Ayyannan, S. R. (2019) · Medicinal Research Reviews · doi:10.1002/med.21561 · Cited by 136 · see citing works

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease

Cuadrado, A., Moreno-Murciano, P., & Pedraza‐Chaverrí, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/13543780802716501 · Cited by 135 · see citing works

Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action

Ostadkarampour, M., & Putnins, E. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.676239 · Cited by 133 · see citing works

Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments

Petrelli, F., Dallérac, G. M., Pucci, L., Calì, C., Zehnder, T., Sultan, S., Lecca, S., Chicca, A., Ivanov, A. D., Asensio, C. S., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0226-y · Cited by 127 · see citing works

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways

Li, C., Han, J., Yao, Q., Zou, C., Xu, Y., Zhang, C., Shang, D., Zhou, L., Zou, C., Sun, Z., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt161 · Cited by 126 · see citing works

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

Lohr, K. M., Masoud, S. T., Salahpour, A., & Miller, G. W. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13357 · Cited by 124 · see citing works

Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?

Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 123 · see citing works

Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

Deurwaerdère, P. D., Giovanni, G. D., & Millan, M. J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.002 · Cited by 123 · see citing works

Beyond the Catecholamines Hypothesis for an Acute Exercise–Cognition Interaction

McMorris, T., Turner, A. P., Hale, B. J., & Sproule, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800778-5.00004-9 · Cited by 122 · see citing works

Threonine aldolases—an emerging tool for organic synthesis

Steinreiber, J., Fesko, K., Reisinger, C., Schürmann, M., van Assema, F., Wolberg, M., Mink, D., & Griengl, H. (2006) · Tetrahedron · doi:10.1016/j.tet.2006.11.035 · Cited by 122 · see citing works

Pharmacological Treatment of Parkinson’s Disease

Zahoor, I., Shafi, A., & Haq, E. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch7 · Cited by 120 · see citing works

Altered vesicular dopamine storage in Parkinson's disease: a premature demise

Caudle, W. M., Colebrooke, R. E., Emson, P. C., & Miller, G. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.010 · Cited by 119 · see citing works

Biochemical Assessment of Pheochromocytoma and Paraganglioma

Eisenhofer, G., Pamporaki, C., & Lenders, J. W. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad011 · Cited by 118 · see citing works

Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone

Anderson, D. G., Mariappan, S. V. S., Buettner, G. R., & Doorn, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249532 · Cited by 117 · see citing works

Catecholamines 101

Goldstein, D. S. (2010) · Clinical Autonomic Research · doi:10.1007/s10286-010-0065-7 · Cited by 112 · see citing works

Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system

Wehrwein, E. A., Orer, H. S., & Barman, S. M. (2016) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2016.tb00714.x · Cited by 114 · see citing works

Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction

Lymperopoulos, A., Rengo, G., Gao, E., Ebert, S. N., Dorn, G. W., & Koch, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077859 · Cited by 111 · see citing works

Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification

Eisenhofer, G., Tischler, A. S., & de Krijger, R. R. (2011) · Endocrine Pathology · doi:10.1007/s12022-011-9188-1 · Cited by 111 · see citing works

Endothelial Cells Are Able to Synthesize and Release Catecholamines Both In Vitro and In Vivo

Sorriento, D., Santulli, G., Giudice, C. D., Anastasio, A., Trimarco, B., & Iaccarino, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189605 · Cited by 111 · see citing works

Hallmarks of peripheral nerve function in bone regeneration

Tao, R., Mi, B., Hu, Y., Lin, S., Xiong, Y., Lu, X., Panayi, A. C., Li, G., & Liu, G. (2023) · Bone Research · doi:10.1038/s41413-022-00240-x · Cited by 110 · see citing works

Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects

Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 107 · see citing works

The acute exercise-cognition interaction: From the catecholamines hypothesis to an interoception model

McMorris, T. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.10.005 · Cited by 107 · see citing works

Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease

Carbone, E., Borges, R., Eiden, L. E., Garcı́a, A. G., & Hernández‐Cruz, A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190003 · Cited by 105 · see citing works

Intragastric administration of capsiate, a transient receptor potential channel agonist, triggers thermogenic sympathetic responses

Ono, K., Tsukamoto‐Yasui, M., Hara-Kimura, Y., Inoue, N., Nogusa, Y., Okabe, Y., Nagashima, K., & Kato, F. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00128.2010 · Cited by 104 · see citing works

Mutations in human monoamine-related neurotransmitter pathway genes

Haavik, J., Blau, N., & Thöny, B. (2008) · Human Mutation · doi:10.1002/humu.20700 · Cited by 104 · see citing works

Current Progress and Future Challenges in the Biochemical Diagnosis and Treatment of Pheochromocytomas and Paragangliomas

Eisenhofer, G., Siegert, G., Kotzerke, J., Bornstein, S. R., & Pacák, K. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1073156 · Cited by 103 · see citing works

Pheochromocytoma: An approach to diagnosis

Sbardella, E., & Grossman, A. B. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101346 · Cited by 103 · see citing works

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease

García‐Pardo, J., Novio, F., Nador, F., Cavaliere, I., Suárez–García, S., Lope‐Piedrafita, S., Candiota, A. P., Romero‐Giménez, J., Rodríguez-Galván, B., Bové, J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00453 · Cited by 103 · see citing works

Peripheral and Central Effects of Circulating Catecholamines

William Tank, A., & Lee Wong, D. (2015) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2015.tb00599.x · Cited by 106 · see citing works

Impact of Short-Term Intake of Red Wine and Grape Polyphenol Extract on the Human Metabolome

Jacobs, D. M., Fuhrmann, J. C., van Dorsten, F. A., Rein, D., Peters, S., van Velzen, E. J. J., Hollebrands, B., Draijer, R., van Duynhoven, J., & Garczarek, U. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2044247 · Cited by 102 · see citing works

Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors

Aslanoglou, D., Bertera, S., Sánchez-Soto, M., Free, R., Lee, J., Zong, W., Xue, X., Shrestha, S., Brissova, M., Logan, R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01171-z · Cited by 88 · see citing works

Forensic Autosomal Short Tandem Repeats and Their Potential Association With Phenotype

Wyner, N., Barash, M., & McNevin, D. B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00884 · Cited by 101 · see citing works

The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea.

Bisogni, V., Pengo, M. F., Maiolino, G., & Rossi, G. P. (2016) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.11.14 · Cited by 100 · see citing works

Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Yao, L., Fan, P., Arolfo, M. P., Jiang, Z., Olive, M. F., Zablocki, J. A., Sun, H.-L., Chu, N., Lee, J., Kim, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2200 · Cited by 99 · see citing works

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

Bharucha, A. E., Charkoudian, N., Andrews, C. N., Camilleri, M., Sletten, D., Zinsmeister, A. R., & Low, P. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2008 · Cited by 98 · see citing works

The Antidepressant Desipramine and α2-Adrenergic Receptor Activation Promote Breast Tumor Progression in Association with Altered Collagen Structure

Szpunar, M. J., Burke, K. A., Dawes, R. P., Brown, E. B., & Madden, K. S. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0079 · Cited by 98 · see citing works

A Fluorescent Biosensors for Detection Vital Body Fluids’ Agents

Nawrot, W., Drzozga, K., Baluta, S., Cabaj, J., & Malecha, K. (2018) · Sensors · doi:10.3390/s18082357 · Cited by 98 · see citing works

Catecholamine Metabolism

Bodton, A. A., & Eisenhofer, G. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60746-2 · Cited by 36 · see citing works

Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.

Eisenhofer, G., Rundquist, B., Åneman, A., Friberg, P., Dakak, N., Kopin, I. J., Jacobs, M. C., & Lenders, J. W. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559889 · Cited by 181 · see citing works

Biochemical Diagnosis of Pheochromocytoma, a Rediscovered Catecholamine-Metabolizing Tumor

Eisenhofer, G., & Lenders, J. W. M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.290791 · Cited by 12 · see citing works

Clues to the Diagnosis of Pheochromocytoma from the Differential Tissue Metabolism of Catecholamines

Eisenhofer, G., & Lenders, J. W. M. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60769-3 · Cited by 5 · see citing works

Pheochromocytoma: Rediscovery as a Catecholamine-Metabolizing Tumor

Eisenhofer, G., Goldstein, D. S., Kopin, I. J., & Crout, J. R. (2003) · Endocrine Pathology · doi:10.1007/s12022-003-0012-4 · Cited by 72 · see citing works